Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Myeloproliferative Diseases
• Myelodysplastic Syndromes

Drugs mentioned

• Fludarabine (Fludarabine)
• Total Body Irradiation

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED